Human CTLA-4 / CD152 Protein, His Tag, active dimer (MALS verified), Unconjugated
Biozol Catalog Number:
ABS-CT4-H52H9-1MG
Supplier Catalog Number:
CT4-H52H9-1mg
Alternative Catalog Number:
ABS-CT4-H52H9-1MG
Manufacturer:
AcroBiosystems
Host:
Human
Category:
Proteine/Peptide
Species Reactivity:
Human
Conjugation:
Unconjugated
CTLA4 (Cytotoxic TLymphocyte Antigen 4) is also known as CD152 (Cluster of differentiation 152), is a protein receptor that downregulates the immune system. CTLA4 is a member of the immunoglobulin superfamily, which is expressed on the surface of Helper T cells and transmits an inhibitory signal to T cells. The protein contains an extracellular V domain, a transmembrane domain, and a cytoplasmic tail. Alternate splice variants, encoding different isoforms. CTLA4 is similar to the Tcell costimulatory protein, CD28, and both molecules bind to CD80 and CD86, also called B71 and B72 respectively, on antigenpresenting cells. CTLA4 transmits an inhibitory signal to T cells, whereas CD28 transmits a stimulatory signal. Intracellular CTLA4 is also found in regulatory T cells and may be important to their function. Fusion proteins of CTLA4 and antibodies (CTLA4Ig) have been used in clinical trials for rheumatoid arthritis. - Proteine/Peptide
Immobilized Human B7-1, Fc Tag (Cat. No. B71-H5259) at 2 µg/mL (100 µL/well) can bind Human CTLA-4, His Tag (Cat. No. CT4-H52H9) with a linear range of 0.1-2 ng/mL (QC tested).
Immobilized Human CTLA-4, His Tag (Cat. No.CT4-H52H9) at 2 µg/mL, add increasing concentrations of CTLA-4 x OX40 Bispecific Antibody in 50% Human serum and then add Biotinylated Human OX40, Avitag,His Tag (Cat. No. TN4-H82E4) at 1 µg/mL. Detection was performed using HRP-conjugated streptavidin with sensitivity of 4 ng/mL (Intact assay, Routinely tested).
Human CTLA-4, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.
* VAT and and shipping costs not included. Errors and price changes excepted
